ACM
APYX icon

AIGH Capital Management’s Apyx Medical APYX Stock Holding History

AIGH Capital Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.08M Hold
1,104,970
– – 0.84% 27
2025
Q4 		$3.87M Buy
+1,104,970
New +$3.85M 1.14% 25
2024
Q1 		– Sell
-2,040,540
Closed -$5.35M – 46
2023
Q4 		$5.35M Buy
2,040,540
+145,309
+8% +$352K 2.12% 18
2023
Q3 		$6.06M Buy
1,895,231
+628,432
+50% +$2.93M 2.87% 13
2023
Q2 		$6.37M Buy
1,266,799
+742,798
+142% +$3.76M 2.6% 10
2023
Q1 		$1.51M Buy
+524,001
New +$1.53M 0.56% 38

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return